Drawing for ASTION

USPTO serial 76139932

ASTION

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
BUCHANAN WILL, NORA
Law office
INTENT TO USE UNIT

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ASTION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Simor L. Moskowitz

SIMOR L MOSKOWITZ JACABSON PRICE HOLMES STERN400 7TH ST NWWASHINGTON, DC 20004-2237UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005BIOLOGICAL AND CHEMICAL PREPARATIONS FOR THE TREATMENT OF VARIOUS ILLNESSES AND DISEASES, NAMELY, PAIN, CANCER, ASTHMA AND RHEUMATOLOGICAL DISEASESACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Mar 11, 2005MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 11, 2005ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 2, 2004EX3GSOU EXTENSION 3 GRANTED—
May 28, 2004CFITCASE FILE IN TICRS—
May 19, 2004EXT3SOU EXTENSION 3 FILED—
May 19, 2004MAILPAPER RECEIVED—
Dec 22, 2003EX2GSOU EXTENSION 2 GRANTED—
Nov 19, 2003EXT2SOU EXTENSION 2 FILED—
Nov 19, 2003MAILPAPER RECEIVED—
Jun 23, 2003EX1GSOU EXTENSION 1 GRANTED—
May 19, 2003EXT1SOU EXTENSION 1 FILED—
May 19, 2003MAILPAPER RECEIVED—
Nov 19, 2002NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 27, 2002PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 7, 2002NPUBNOTICE OF PUBLICATION—
Apr 22, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 4, 2002CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 15, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 2, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 2, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 10, 2001DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance